Abstract
The identification and hit-to-lead exploration of a novel, potent and selective series of histamine H(4) receptor inverse agonists is described. The initial hit, 3A (IC(50) 19 nM) was identified by means of a ligand-based virtual screening approach. Subsequent medicinal chemistry exploration yielded 18I which possessed increased potency (R-enantiomer IC(50) 1 nM) as well as enhanced microsomal stability.
Copyright 2010 Elsevier Ltd. All rights reserved.
MeSH terms
-
Animals
-
Biological Availability
-
Drug Discovery
-
Histamine Antagonists / chemistry
-
Histamine Antagonists / pharmacokinetics
-
Histamine Antagonists / pharmacology*
-
Inhibitory Concentration 50
-
Macaca fascicularis
-
Rats
-
Receptors, G-Protein-Coupled / antagonists & inhibitors*
-
Receptors, Histamine
-
Receptors, Histamine H4
-
Stereoisomerism
Substances
-
Histamine Antagonists
-
Hrh4 protein, rat
-
Receptors, G-Protein-Coupled
-
Receptors, Histamine
-
Receptors, Histamine H4